LifePoint Health, Inc. (LPNT) Expected to Post Earnings of $0.91 Per Share

Wall Street analysts expect LifePoint Health, Inc. (NASDAQ:LPNT) to report earnings per share (EPS) of $0.91 for the current quarter, Zacks reports. Nine analysts have issued estimates for LifePoint Health’s earnings. The lowest EPS estimate is $0.83 and the highest is $0.96. LifePoint Health posted earnings per share of $0.71 during the same quarter last year, which indicates a positive year-over-year growth rate of 28.2%. The business is scheduled to issue its next earnings results on Friday, August 4th.

According to Zacks, analysts expect that LifePoint Health will report full-year earnings of $4.19 per share for the current fiscal year, with EPS estimates ranging from $4.09 to $4.30. For the next financial year, analysts forecast that the company will post earnings of $4.64 per share, with EPS estimates ranging from $4.41 to $4.83. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that follow LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, April 28th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.06. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.06% and a net margin of 2.26%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.85 earnings per share.

LPNT has been the subject of several recent analyst reports. TheStreet raised shares of LifePoint Health from a “c+” rating to a “b-” rating in a report on Monday, March 13th. Morgan Stanley initiated coverage on shares of LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 target price for the company. Barclays PLC upped their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the stock an “equal weight” rating in a report on Monday, May 1st. BidaskClub raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Finally, Deutsche Bank AG began coverage on shares of LifePoint Health in a report on Tuesday, April 4th. They issued a “hold” rating and a $68.00 target price for the company. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $65.46.

In related news, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total value of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares of the company’s stock, valued at approximately $32,365,920.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John P. Bumpus sold 33,333 shares of the stock in a transaction dated Thursday, March 30th. The stock was sold at an average price of $65.00, for a total transaction of $2,166,645.00. Following the completion of the sale, the executive vice president now directly owns 143,829 shares in the company, valued at $9,348,885. The disclosure for this sale can be found here. Insiders sold a total of 117,680 shares of company stock worth $7,574,965 over the last three months. 7.28% of the stock is currently owned by corporate insiders.

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. raised its stake in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after buying an additional 3,714,004 shares during the period. Dimensional Fund Advisors LP increased its position in shares of LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock worth $221,969,000 after buying an additional 18,327 shares in the last quarter. Vanguard Group Inc. increased its position in shares of LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock worth $213,986,000 after buying an additional 120,201 shares in the last quarter. Wellington Management Group LLP increased its position in shares of LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock worth $213,351,000 after buying an additional 168,451 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock worth $113,049,000 after buying an additional 68,886 shares in the last quarter. 99.80% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “LifePoint Health, Inc. (LPNT) Expected to Post Earnings of $0.91 Per Share” was published by Mideast Time and is owned by of Mideast Time. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.mideasttime.com/lifepoint-health-inc-lpnt-expected-to-post-earnings-of-0-91-per-share/1804420.html.

Shares of LifePoint Health (NASDAQ LPNT) opened at 67.10 on Friday. LifePoint Health has a 52-week low of $50.60 and a 52-week high of $70.95. The firm’s 50 day moving average price is $62.66 and its 200 day moving average price is $61.53. The stock has a market cap of $2.71 billion, a P/E ratio of 17.70 and a beta of 0.94.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:LPNT”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.